Abstract:Trauma is the leading cause of death for adults under the age of 44. Internal bleeding remains a significant challenge in medical emergencies, necessitating the development of effective hemostatic materials that could be administered by paramedics before a patient is in the hospital and treated by surgeons. In this study, we introduce a graphene oxide (GO)-based PEGylated synthetic hemostatic nanomaterial with an average size of 211 ± 83 nm designed to target internal bleeding by mimicking the role of fibrinogen. Functionalization of GO-g-PEG with peptides derived from the α-chain of fibrinogen, such as GRGDS, or the γ-chain of fibrinogen, such as HHLGGAKQAGDV:H12, was achieved with peptide loadings of 72 ± 6 and 68 ± 15 μM, respectively. In vitro studies with platelet-rich plasma (PRP) under confinement demonstrated aggregation enhancement of 39 and 24% for GO-g-PEG-GRGDS and GO-g-PEG-H12, respectively, compared to buffer, while adenosine diphosphate (ADP) alone induced a 5% aggregation. Compared to the same materials in the absence of ADP, GO-g-PEG-GRGDS achieved a 47% aggregation enhancement, while GO-g-PEG-H12 a 25% enhancement. This is particularly important for injectable hemostats and highlights the fact that our nanographene-based materials can only act as hemostats in the presence of agonists, reducing the possibility of unwanted clotting during circulation. Further studies on collagen-coated wells under dynamic flow revealed statistically significant augmentation of PRP fluorescence signal using GRGDS- or H12-coated GO-g-PEG compared to controls. Hemolysis studies showed <1% lysis of red blood cells (RBCs) at the highest PEGylated nanographene concentration. Finally, whole human blood coagulation studies reveal faster and more pronounced clotting using our nanohemostats vs PBS control from 3 min and below (blood is clotted with 10% CaCl2 within 4-5 min), with the biggest differences to be shown at 2 and 1 min. At 1 min, the clot weight was found to be ∼45% of that between 4 and 5 min, while no clot was formed in PBS-treated blood. Reduction of CaCl2 to 5 and 3%, or utilization of prostaglandin E1, an anticoagulant, still leads to clots but of smaller weight. The findings highlight the potential of our fibrinogen-mimic PEGylated nanographene as a promising non-hemolytic injectable scaffold for targeting internal bleeding, offering insights into its platelet aggregation capabilities under confinement and under dynamic flow as well as its pronounced coagulation abilities.

Fabrication of Injectable and Superelastic Nanofiber Rectangle Matrices ("peanuts") and Their Potential Applications in Hemostasis.

Conjugate Electrospun 3D Gelatin Nanofiber Sponge for Rapid Hemostasis

Nanofibrous hemostatic materials: Structural design, fabrication methods, and hemostatic mechanisms

Flexible Biomimetic Hollow Al2O3 Fibers for Safe and Effective Hemostasis

Experimental Study on Rapid Hemostasis Using Peptide Hydrogels

Highly Resilient, Biocompatible, and Antibacterial Carbon Nanotube/hydroxybutyl Chitosan Sponge Dressing for Rapid and Effective Hemostasis.

A Novel Pullulan Oxidation Approach to Preparing a Shape Memory Sponge with Rapid Reaction Capability for Massive Hemorrhage

Safe and Efficacious Near Superhydrophobic Hemostat for Reduced Blood Loss and Easy Detachment in Traumatic Wounds

Conjugate Electrospun 3D Gelatin Nanofiber Sponge for Rapid Hemostasis (adv. Healthcare Mater. 20/2021)

Non-cross-linked collagen type I microfibers for improved hemostasis and wound healing

A facile way to fabricate a thrombin immobilized composite sponge with dual hemostatic effects for acute hemorrhage control

Swift Covalent Gelation Coupled with Robust Wet Adhesive Powder: A Novel Approach for Acute Massive Hemorrhage Control in Dynamic and High-Pressure Wound Environments

Injectable Antibacterial Conductive Nanocomposite Cryogels with Rapid Shape Recovery for Noncompressible Hemorrhage and Wound Healing

Naturally Derived Injectable Dual-Cross-Linked Adhesive Hydrogel for Acute Hemorrhage Control and Wound Healing

Fabrication of Curcumin-Loaded Mesoporous Silica Incorporated Polyvinyl Pyrrolidone Nanofibers for Rapid Hemostasis and Antibacterial Treatment

Double-network structure sponge with enhanced mechanical properties, procoagulant potential, and 3D printability for acute hemorrhage

NanoGraphene Clot: A New Fibrinogen-Mimic Hemostatic Material

Engineering High-Performance Composite Cellulose Materials for Fast Hemostasis

Shape-Recoverable Macroporous Nanocomposite Hydrogels Created Via Ice Templating Polymerization for Noncompressible Wound Hemorrhage

Short Peptide Nanofiber Biomaterials Ameliorate Local Hemostatic Capacity of Surgical Materials and Intraoperative Hemostatic Applications in Clinics

Design of dry/wet-loaded drug composite materials with sandwich structure for efficient synergistic hemostasis